Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of Washington
University of Ulm
BeOne Medicines
Eli Lilly and Company
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Gilead Sciences
Incyte Corporation